3 Cheap Under-$10 Stocks to Buy With $500

Investors looking to buy lower-priced stocks can add WELL Health and HIVE stocks to their portfolios right now.

| More on:
money cash dividends

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Stocks that have lower prices always seem to be attractive bets to investors. You can hold investments in multiple companies with a smaller amount of capital, which will also allow you to diversify your portfolio. Here, we’ll look at three lower-priced stocks you can buy with just $500.

WELL Health Technologies

One of the best-performing stocks on the TSX, WELL Health Technologies (TSX:WELL) has returned an astonishing 7,000% to investors since its IPO in April 2016. WELL Health is a company that aims to digitize and automate several healthcare processes.

With a focus on aggressive acquisitions, WELL Health sales have increased from $414,000 in 2017 to $50.24 million in 2020. In the last 12 months, its sales have risen to $116.78 million and are forecast to touch $282 million in 2021 and $441 million in 2022.

While the company reported an operating loss of $10.4 million in 2020, analysts expect WELL Health to report adjusted earnings per share of $0.04 in 2022. WELL Health stock is currently trading 50% below its price target consensus estimates and is grossly undervalued, given it’s valued at a very reasonable price-to-2022-sales multiple of 3.8.

HIVE Blockchain Technologies

Cryptocurrency mining company HIVE Blockchain Technologies (TSXV:HIVE) is valued at a market cap of $1.5 billion. It mines digital assets, including Ethereum, Bitcoin, and Ethereum Classic. The price of a mining company is closely tied to the cryptocurrency it mines.

The price of each Ether rose from $11.95 in October 2016 to $1,400 in January 2018 before falling to $128 in December 2019. It’s now trading at $3,418. Similarly, the price of each HIVE stock rose from $0.10 in October 2016 to $4.71 in November 2017 and fell to $0.11 in January 2020. It’s currently trading at $4 per share.

Ethereum is well poised to maintain its leadership position in the cryptocurrency space, given its widespread adoption by institutions as well as the rapid rise in non-fungible tokens and decentralized finance projects.

HIVE stock should be part of your portfolio if you are bullish on Ethereum. In late July, the company confirmed that it’s generating a daily income of $550,000, indicating an annual run rate of $200 million based on the Ethereum and Bitcoin prices at that time. Comparatively, its annual run rate operating and overhead costs were just $25 million.

CloudMD

Another health-tech stock that makes the list is CloudMD (TSXV:DOC), a small-cap company valued at a market cap of $401 million. Similar to WELL Health, CloudMD has also managed to grow its top line at a stellar pace. Its sales have risen from $1.2 million in 2018 to $15 million in 2020. It’s forecast to grow by 552% to $98 million in 2021 and 65% to $161.7 million in 2022.

The company offers software-as-a-service solutions to medical clinics in North America. This suite of solutions allows clinics to deliver quality healthcare to patients. CloudMD ecosystem spans 500 clinics and 400 licensed practitioners.

The telehealth market is expected to touch $559.5 billion in 2027, up from just $61.4 billion in 2021, making CloudMD stock a top bet for long-term growth investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »